Skip to Content

WATSON 782 (Diethylpropion Hydrochloride Extended-Release 75 mg)

Pill with imprint WATSON 782 is White, Elliptical / Oval and has been identified as Diethylpropion Hydrochloride Extended-Release 75 mg. It is supplied by Watson Pharmaceuticals.

Diethylpropion is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. There is no proven risk in humans during pregnancy. Diethylpropion 75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 782

Diethylpropion hydrochloride extended-release 75 mg WATSON 782
Diethylpropion hydrochloride extended-release 75 mg WATSON 782  Front
Diethylpropion hydrochloride extended-release 75 mg WATSON 782  Back
Diethylpropion hydrochloride extended-release 75 mg WATSON 782

Diethylpropion Hydrochloride Extended-Release

Imprint
WATSON 782
Strength
75 mg
Color
White
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Anorexiants, CNS stimulants
Pregnancy Category
B - No proven risk in humans
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
carbomer homopolymer type B, mannitol, povidone, tartaric acid, zinc stearate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-0782 Watson Pharmaceuticals, Inc.
54569-0396 A-S Medication Solutions, LLC (repackager)
54868-1463 Physicians Total Care Inc. (repackager)
49999-0457 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.